Results 101 to 110 of about 2,525 (153)

Evaluation of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor combinations and colistin in carbapenem-non-susceptible gram-negative bacilli. [PDF]

Microbiol Spectr
Kim TY, Baek JY, Suh E, Lee J-K, Yu H-J, Ko J-H, Huh HJ, Lee NY.   +7 more
europepmc   +1 more source

Molecular characterization of carbapenem-resistant Enterobacterales (CRE) and <i>in vitro</i> activity of novel beta lactams against CRE isolates from Malaysia. [PDF]

Microbiol Spectr
Rashid FA, Suhaila Che Hussin N, Anuar NFZ, Sahlan N, Palanisamy NK, Mohd Nor F.   +5 more
europepmc   +1 more source

Efficacy of Imipenem/Cilastatin/Relebactam in infections caused by Difficult-to-Treat Gram-Negative Bacteria: A Retrospective Analysis of Real-world data in Greece. [PDF]

Infez Med
Petrakis V, Rafailidis P, Panopoulou M, Konstantinidis T, Babaka N, Papazoglou D, Panagopoulos P.   +6 more
europepmc   +1 more source

Deciphering the emergence of mutations in Pseudomonas aeruginosa after ceftolozane/tazobactam treatment and evaluating therapeutic alternatives. [PDF]

BMC Microbiol
Bientz L, Boijout H, Grami R, Guyet U, Lahouati M, Hertzmann M, Marques A, Toirot A, Aillerie S, Coulange-Mayonnove L, Groppi A, Nikolski M, Bébéar C, Dubois V.   +13 more
europepmc   +1 more source

One-year surveillance of last-resort antimicrobial resistance patterns in carbapenemase-producing <i>Klebsiella pneumoniae</i> strains isolated in a Romanian tertiary care hospital: a prospective study. [PDF]

Germs
Dan MO, Florea D, Rafila A, Turcitu M, Turcitu DF, Tălăpan D.   +5 more
europepmc   +1 more source

Global trends in carbapenem-resistant gram-negative bacteria research (2020-2025): a bibliometric analysis and systematic review. [PDF]

Front Cell Infect Microbiol
Zhang X, Zhang C, Lv M, Wang S, Wang Q, Yang C, Zhao Q, Ma L, Li B, Qin X, Zhao C, Shen C.   +11 more
europepmc   +1 more source

Significant Prevalence of Dual KPC/NDM Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in an ICU Cohort in Thessaloniki (2023), Including an ST512 Isolate Co-Harboring <i>bla_NDM-1</i> and <i>bla_KPC-3</i>. [PDF]

Antibiotics (Basel)
Chatzidimitriou M, Voulgaridis A, Tsolakidou P, Chatzopoulou F, Chonianakis I, Vagdatli E, Kachrimanidou M, Vyzantiadis TA.   +7 more
europepmc   +1 more source

Genomic and molecular characterisation of a KPC-producing Klebsiella pneumoniae clinical isolate resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam

Wan Y, Wong JLC, Sanchez-Garrido J, Low WW, Turton JF, Morecchiato F, Baccani I, Dodgson K, Rossolini GM, Woodford N, Frankel G, Jauneikaite E, Meunier D, Hopkins KL.   +13 more
europepmc   +1 more source

Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]

JAC Antimicrob Resist
Sader HS, Mendes RE, Kimbrough JH, Papp-Wallace KM, Winkler ML, Castanheira M.   +5 more
europepmc   +1 more source